Intarcia Diabetes Implant Shows Promising Results During Phase 3 Trials U.S.-based pharmaceutical company Intarcia Therapeutics reported that its new diabetes pump known as ITCA 650 was able to reduce weight and lower blood glucose levels better than Merck & Co's best-selling product Januvia. by Ted Ranosa